Qian Xiaoqiang, Sheng Xujun, Li Ruipeng, Liu Hailong, Kong Xiangjie, Duan Liujian, Qi Jun
Department of Urology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
PLoS One. 2015 May 4;10(5):e0120696. doi: 10.1371/journal.pone.0120696. eCollection 2015.
To study retrospectively the efficacy of decortication in patients with different stages of ADPKD and to determine which stage for decortication is more appropriate.
We analyzed 137 patients with ADPKD from 2001 to 2010. All patients were divided into three stages. A total of 70 patients underwent decortication, and we studied intraoperative indicators and postoperative indicators at 1 and 3 years follow-up.
In 70 patients who underwent decortication, significant differences were observed in operative duration and bleeding volume between patients with stage I and II ADPKD (P<0.05), but no significant differences were observed in intestinal recovery time, pain medication dose, and the days of postoperative hospitalization (P > 0.05). The total complication occurrence rate was significantly different between them (P < 0.05). The serum creatinine (Scr) levels in patients with stage I ADPKD were within normal limits 1 and 3 years postoperatively and did not differ significantly (P > 0.05). Scr levels were significantly decreased in patients with stage II ADPKD in the 1st postoperative year (P < 0.05), but these were not significant differences in the 3rd postoperative year (P > 0.05). In the 1st postoperative year, VAS value, blood pressure and renal volume significantly differed (P < 0.05). However, no significant differences were observed 3 years later (P > 0.05).
Decortication in patients with stage I ADPKD can alleviate back pain symptoms and decrease blood pressure within 1 year, but the long-term efficacy is not ideal. Scr levels can be maintained within normal limits, suggesting that decortication does not lead to deterioration of renal function. For patients with stage II ADPKD, decortication can significantly improve renal function over the short term. However, after 3 years, renal function returns to the preoperative level, and surgical difficulties and complications also increase.
回顾性研究去皮质术治疗不同阶段常染色体显性多囊肾病(ADPKD)患者的疗效,并确定去皮质术更适合的阶段。
分析2001年至2010年137例ADPKD患者。所有患者分为三个阶段。共70例患者接受了去皮质术,我们研究了术中指标以及术后1年和3年随访时的术后指标。
在70例行去皮质术的患者中,I期和II期ADPKD患者的手术时长和出血量存在显著差异(P<0.05),但肠道恢复时间、止痛药物剂量和术后住院天数无显著差异(P>0.05)。两者的总并发症发生率存在显著差异(P<0.05)。I期ADPKD患者术后1年和3年的血清肌酐(Scr)水平在正常范围内,且无显著差异(P>0.05)。II期ADPKD患者术后第1年Scr水平显著降低(P<0.05),但术后第3年无显著差异(P>0.05)。术后第1年,视觉模拟评分(VAS)值、血压和肾体积有显著差异(P<0.05)。然而,3年后无显著差异(P>0.05)。
I期ADPKD患者行去皮质术可在1年内缓解背痛症状并降低血压,但长期疗效不理想。Scr水平可维持在正常范围内,表明去皮质术不会导致肾功能恶化。对于II期ADPKD患者,去皮质术可在短期内显著改善肾功能。然而,3年后,肾功能恢复到术前水平,手术难度和并发症也会增加。